University of Cambridge > > GBR talks > Challenging the price of drugs

Challenging the price of drugs

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Krishnaa Mahbubani.

Why does developing drugs cost so much? Why does it take so long? What is the difference between branded and generic drugs?

These questions are discussed by a panel including Professor Gerard Evan (HOD Biochemistry), Angela Williams (Director Health Outcomes and Pharmacoeconomics, MedImmune) and Iain Scott (Senior Analyst, Ernst & Young) whilst an understanding of drug development is established

This talk is part of the GBR talks series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity